atorvastatin has been researched along with Colitis in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Caviglia, GP; Ribaldone, DG; Vernero, M | 1 |
Alves, VBF; Basso, PJ; Bonfá, G; Cardoso, CRB; Chica, JEL; Duarte-Silva, M; Ghirotto, B; Nardini, V; Nomizo, A; Rodrigues, CC; Sales-Campos, H | 1 |
Hobbenaghi, R; Malekinejad, H; Moshtaghion, SM; Shafie-Irannejad, V; Tabatabaie, SH | 1 |
Akhavan, MM; Chamanara, M; Dehpour, AR; Mehr, SE; Mousavi, SE; Muhammadnejad, A; Rashidian, A; Rezayat, SM; Shirkoohi, R | 1 |
Cao, Y; Chen, H; He, Y; Lei, A; Li, X; Shi, M; Xiao, Q; Yang, Q; Zhou, J | 1 |
Aktunc, E; Arasli, M; Barut, F; Gun, BD; Kayhan, B | 1 |
Guan, F; Ju, J; Li, G; Liu, AB; Sun, Y; Yang, CS; Yang, Z | 1 |
Kanagarajan, N; Murthy, S; Nam, JH; Noah, ZA | 1 |
8 other study(ies) available for atorvastatin and Colitis
Article | Year |
---|---|
Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signalling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuate progression of oxazolone-induced colitis.
Topics: Anti-Inflammatory Agents; Atorvastatin; Colitis; Gene Expression; Humans; Interleukin-10; Interleukin-6; Mesalamine; Oxazolone | 2021 |
Peroxisome Proliferator-Activated Receptor Alpha Mediates the Beneficial Effects of Atorvastatin in Experimental Colitis.
Topics: Animals; Atorvastatin; Colitis; Dextran Sulfate; Interleukin-10; Interleukin-6; Male; Mice; Mice, Knockout; PPAR alpha; Th17 Cells; Th2 Cells | 2021 |
Comparative protective effect of hawthorn berry hydroalcoholic extract, atorvastatin, and mesalamine on experimentally induced colitis in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Atorvastatin; Colitis; Crataegus; Fruit; Heptanoic Acids; Humans; Lipid Peroxidation; Male; Mesalamine; Plant Extracts; Pyrroles; Rats; Rats, Wistar | 2013 |
Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway.
Topics: Animals; Atorvastatin; Colitis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; NF-kappa B; Random Allocation; Rats; Rats, Wistar; Signal Transduction; Toll-Like Receptor 4; Trinitrobenzenesulfonic Acid | 2016 |
Atorvastatin promotes the expansion of myeloid-derived suppressor cells and attenuates murine colitis.
Topics: Animals; Anti-Inflammatory Agents; Atorvastatin; Cells, Cultured; Colitis; Dextran Sulfate; Humans; Immunosuppression Therapy; Mevalonic Acid; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Myeloid-Derived Suppressor Cells; Nitric Oxide; T-Lymphocytes | 2016 |
The effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis.
Topics: Acute Disease; Animals; Atorvastatin; Colitis; Cytokines; Disease Models, Animal; Down-Regulation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Mice; Mice, Inbred BALB C; Pyrroles; Th1 Cells; Th2 Cells | 2011 |
Deleterious effects of high concentrations of (-)-epigallocatechin-3-gallate and atorvastatin in mice with colon inflammation.
Topics: Animals; Atorvastatin; Azoxymethane; Catechin; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Heptanoic Acids; Leukotriene B4; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Pyrroles; Rectum; Weight Loss | 2012 |
Disease modifying effect of statins in dextran sulfate sodium model of mouse colitis.
Topics: Animals; Apolipoprotein A-I; Atorvastatin; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, HDL; Mice; Occult Blood; Pyrroles; Simvastatin; Tumor Necrosis Factor-alpha | 2008 |